Skip to main content

Table 3 The results of subgroup meta-analysis

From: CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis

SubgroupCohortHR or RR95%CIP valueI2
Long-term outcome (HR)-Overall survival
 Overall201.6021.369–1.873< 0.00159.5%
 Asian countries121.7761.556–2.026< 0.00141.9%
 Non-Asian countries81.3681.117–1.6760.00260.1%
 Zhuang criteria21.6221.326–1.983< 0.0010%
 Martin criteria51.3431.200–1.503< 0.0010%
 Prado criteria61.9760.934–4.1820.07574.2%
 CRC surgery71.5231.201–1.9300.00163.1%
 EC surgery51.5671.089–2.2530.01552.9%
 GC surgery81.7031.281–2.262< 0.00160.6%
Long-term outcome (HR)-Disease-free survival
 Overall111.4611.297–1.646< 0.0010%
 Asian countries91.5661.357–1.808< 0.0010%
 Non-Asian countries21.2551.014–1.5530.0370%
 Zhuang criteria21.5681.274–1.930< 0.0010%
 Martin criteria31.2491.024–1.5230.0280%
 Prado criteria31.2710.778–2.0750.3380%
 CRC surgery41.2821.058–1.5540.0110%
 EC surgery12.0600.626–6.7830.235
 GC surgery61.5781.355–1.839< 0.0010%
Short-term outcome (RR)-Total complication after surgery
 Overall151.1881.083–1.303< 0.00126.4%
 Asian countries101.1651.046–1.2980.00543.9%
 Non-Asian countries51.2521.045–1.4990.0150%
 Zhuang criteria41.4231.214–1.667< 0.0010%
 Martin criteria51.2461.017–1.5270.0340%
 Prado criteria21.0740.842–1.3710.5650%
 CRC surgery61.3141.101–1.5680.0020%
 EC surgery41.0510.900–1.2260.5310%
 GC surgery51.2181.046–1.4190.01161.9%
Short-term outcome (RR)-Major complication after surgery
 Overall141.2281.042–1.4480.01412.1%
 Asian countries71.2441.001–1.5450.04945.9%
 Non-Asian countries71.2060.936–1.5530.1480%
 Zhuang criteria22.0841.359–3.1960.00150%
 Martin criteria50.9880.690–1.4130.9460%
 Prado criteria41.3090.978–1.7500.0700%
 CRC surgery40.8990.545–1.4810.6750%
 EC surgery41.1810.932–1.4950.1690%
 GC surgery61.3931.076–1.8030.01248.3%
  1. Abbreviation: RR relative risk, HR hazard ratio, CI confidence interval, EC esophageal cancer, GC gastric cancer, CRC colorectal cancer